Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane as First-Line Therapy for Metastatic Breast Cancer
NCT00456846Phase 2Terminated
- Sponsor
- Celgene Corporation
- Start
- Feb 2008
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Celgene Corporation. Started Feb 2008; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00456846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456846.